Kinase inhibitory potencies and in vitro antiproliferative activities of N-10 substituted pyrrolo[2,3-a]carbazole derivatives
Graphical abstract
Section snippets
Acknowledgments
CNRS Valorisation (R.A.-G.) and French Ministère de l’Enseignement Supérieur et de la Recherche (E.S.) are greatly acknowledged for financial support. The authors are grateful to Bertrand Légeret for mass spectrometry analysis.
References and notes (14)
- et al.
J. Biol. Chem.
(2005) - et al.
Cancer Cell
(2003) - et al.
Drug Resist. Updat.
(2011) - et al.
Bioorg. Med. Chem.
(2010) - et al.
Eur. J. Med. Chem.
(2012) - et al.
Haematologica
(2010) - et al.
Nat. Genet.
(2002)
Cited by (33)
Synthesis, kinase inhibition and anti-leukemic activities of diversely substituted indolopyrazolocarbazoles
2024, European Journal of Medicinal ChemistryBiological evaluation of carbazoyl hydrazine derivatives as potential Pim-1 kinase inhibitors for the treatment of human liver cancer
2024, Journal of Molecular StructureTopical advances in PIM kinases and their inhibitors: Medicinal chemistry perspectives
2022, Biochimica et Biophysica Acta - Reviews on CancerCitation Excerpt :Pharmacodynamics studies of 94 were performed on Balb/c mice carrying adenocarcinoma, administration of 50 mg/kg dose for 5 days per week that resulted in subsequent decrease of the tumor volume to 50% and did not impart any toxicity. Molecular docking studies suggested that 93 was occupied in the active site of the PIM-1 kinase and showed interaction of N3 of thiazolidinedione with Glu121 in the hinge region, trifluoromethylphenyl group occupied the hydrophobic region which depicted van der Waals interactions which stated that 93 contributed to be Type-1 inhibitor of PIM-1 kinase [71]. New PIM kinase inhibitors derived from pyrazoloquinazoline carboxylate as PIM-1 kinase inhibitors reported as anticancer agents.
Synthesis and biological activities of new pyrrolocarbazole-imidazobenzimidazole conjugates
2020, Tetrahedron LettersCitation Excerpt :First, we attempted to prepare the carboxylic acid derivative 6 either from primary alcohols 2 or 3. Compound 11 was reacted with 1,4-dibromobutane in order to prepare the known N-substituted 4-bromobutyl intermediate [11]. Chromatography on silica gel was performed to remove 1,4-dibromobutane before substitution of the bromine atom by a hydroxyl group in DMSO/H2O in the presence of K2CO3 [12].
Bufothionine exerts anti-cancer activities in gastric cancer through Pim3
2019, Life SciencesCitation Excerpt :Interestingly, PIM3 is unregulated in cancerous tissues, especially endoderm-derived tumors including the colon, liver, pancreas, and stomach [4,7,8]. Since then, small molecule Pim kinase inhibitors were developed [35,36]. An earlier study showed that a stemonamide synthetic intermediate, named T-18, exhibited anticancer activities against GC by functioning as a PIM3 inhibitor [37].
Synthesis and Applications of Dihydropyrrolocarbazoles
2019, European Journal of Organic Chemistry